Last reviewed · How we verify
A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study
The primary objective of this study is to evaluate two pharmacotherapeutic approaches to sleep induction, both of which have been shown to be effective hypnotics, but may have unique side effect profiles. These profiles may have markedly different impacts on performance in a military setting. In this randomized, double-blind, placebo controlled study, the side effects of these drugs will be compared - suvorexant, a dual orexin receptor antagonist and zolpidem, a non-benzodiazepine gamma-aminobutyric acid (GABA) A agonist - in healthy controls comparable in age and gender to the target military population.
Details
| Lead sponsor | Walter Reed Army Institute of Research (WRAIR) |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 90 |
| Start date | Sun Dec 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Dec 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Performance Enhancing Product Use
Interventions
- Suvorexant 10 mg
- Zolpidem
- Placebos
Countries
United States